APA (7th ed.) Citation

A, G., A, C., F, T., D, C., MJ, R., D, M., . . . J, M. (2023). Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice. The Journal of antimicrobial chemotherapy, 78(10), 2591. https://doi.org/10.1093/jac/dkad278

Chicago Style (17th ed.) Citation

A, Gonzalez-Serna, et al. "Response to Glecaprevir/pibrentasvir in HIV/HCV-coinfected Patients in Clinical Practice." The Journal of Antimicrobial Chemotherapy 78, no. 10 (2023): 2591. https://doi.org/10.1093/jac/dkad278.

MLA (9th ed.) Citation

A, Gonzalez-Serna, et al. "Response to Glecaprevir/pibrentasvir in HIV/HCV-coinfected Patients in Clinical Practice." The Journal of Antimicrobial Chemotherapy, vol. 78, no. 10, 2023, p. 2591, https://doi.org/10.1093/jac/dkad278.